EXPE
88
2
PNW
66
3
BBY
40
3
ACN
47
-2
IP
70
2
HRL
39
15
MTCH
37
7
RRC
63
3
HCP
58
4
SYF
85
2
HRB
51
2
ETR
68
3
AXP
66
2
ICE
59
-3
ALLE
37
5
SRE
63
-3
PX
75
5
ZBH
60
-2
XOM
47
5
HSY
34
3
EXPE
88
2
PNW
66
3
BBY
40
3
ACN
47
-2
IP
70
2
HRL
39
15
MTCH
37
7
RRC
63
3
HCP
58
4
SYF
85
2
HRB
51
2
ETR
68
3
AXP
66
2
ICE
59
-3
ALLE
37
5
SRE
63
-3
PX
75
5
ZBH
60
-2
XOM
47
5
HSY
34
3
Financhill
Back

Bioxytran 10K Form

Sell
34

BIXT
Bioxytran

Last Price:
0.1000
Seasonality Move:
509.54%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive BIXT News And Ratings

See the #1 stock for the next 7 days that we like better than BIXT

BIXT Financial Statistics

Sales & Book Value

Annual Sales: $191.08K
Cash Flow: $21.2K
Price / Cash Flow: 0
Annual Sales: $-0.01
Price / Book: 0

Profitability

EPS (TTM): -0.01180
Net Income (TTM): $-2.81M
Gross Margin: $87.1K
Return on Equity: 0%
Return on Assets: 0%

Bioxytran Earnings Forecast

Key Bioxytran Financial Ratios

  • The Gross Profit Margin over the past 10 years for BIXT is 45.58%.
  • The Selling, General & Administrative Expenses for BIXT have been equal to 208.13% of Gross Profit Margin.
  • The Interest Expense is -12.66% of Operating Income.
  • Per Share Earnings over the last 16 years have been positive in 8 years.

Bioxytran Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: OTCM
Industry: Biotechnology
Sector: Health Care
Current Symbol: BIXT
Website: bioxytraninc.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

BIXT Technical Analysis vs Fundamental Analysis

Sell
34
Bioxytran (BIXT) is a Sell

Is Bioxytran a Buy or a Sell?

  • Bioxytran stock is rated a Sell
    The current Bioxytran [BIXT] share price is $0.0987. The Score for BIXT is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.